FINNENCE ▪ THE WIRE FILE
THE WIRE · № 69309
News■ Unclear/unknown
tgin Foundation's 9th Annual Cocktails for the Cure Gala Returns to Advance Breast Health Equity and Expand Access to Care
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 15:00 UTC
LAST UPDATE2026-10-07 15:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A charity gala fundraising target has no market or company financial relevance.
Charity event, no investable content
CATALYST TO WATCH
None disclosed
MAIN RISK
No financial market linkage
FULL DISPATCH
The signature fundraising event aims to raise $150,000 to support women and families navigating breast cancer CHICAGO, Oct. 7, 2026 /PRNewswire/ -- The tgin Foundation's 9th Annual Cocktails for the Cure Gala will take place on Saturday, October 10, 2026, from 6:00 p.m. to 10:00 p.m. at...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Omega Healthcare Is Recognized Across Three Categories in Avtar & Seramount's 2026 Best Companies Rankings2026-10-07 15:00 UTC
Omega Healthcare Is Recognized Across Three Categories in Avtar & Seramount's 2026 Best Companies Rankings2026-10-07 15:00 UTC
→CORRELATIONshares Healthcare
InventHelp Inventor Develops Hot/Cold Therapy Cap for the Head & Neck (MHO-686)2026-10-07 15:15 UTC
InventHelp Inventor Develops Hot/Cold Therapy Cap for the Head & Neck (MHO-686)2026-10-07 15:15 UTC
→CORRELATIONshares Healthcare
GovCIO Partners with CLEAR to Pilot a New Way for Veterans to Securely Access VA.gov2026-10-07 15:26 UTC
GovCIO Partners with CLEAR to Pilot a New Way for Veterans to Securely Access VA.gov2026-10-07 15:26 UTC
→CORRELATIONshares Healthcare
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi2026-10-07 12:00 UTC
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi2026-10-07 12:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.